National Cancer Institute; Notice of Closed Meetings, 77624-77625 [2022-27417]
Download as PDF
<![CDATA[
77624
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
Dated: December 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–27418 Filed 12–16–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
tkelley on DSK125TN23PROD with NOTICE
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications
and contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Survivorship Needs of Individuals with
Advanced Cancer.
Date: January 12, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH
9609, Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 8A:
Contract Review Meeting.
Date: February 1, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Program and Review
Extramural Staff Training Office, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W534, Rockville, Maryland 20850,
240–276–6444, dingi@mail.nih.gov.
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches into
Clinical Assay Development.
Date: February 1, 2023.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 8B:
SBIR Review Meeting.
Date: February 2, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Program and Review
Extramural Staff Training Office, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W534, Rockville, Maryland 20850,
240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Informatics Technologies for
Cancer Research and Management.
Date: February 2, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Institutional
Training and Education Study Section (F).
Date: February 22–23, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W234, Rockville, Maryland 20850,
240–276–6368, Stoicaa2@mail.nih.gov.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Outstanding Investigator Award (R35).
Date: February 23–24, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: David G. Ransom, Ph.D.,
Chief, Scientific Review Officer, Special
Review Branch Division of Extramural
Activities, National Cancer Institute, NIH
9609, Medical Center Drive, Room 7W104,
Rockville, Maryland 20850, 240–276–6351,
david.ransom@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–3:
SBIR Contract Review Meeting.
Date: February 24, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W236, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Shuli Xia, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W236, Rockville, Maryland 20850,
240–276–5256, shuli.xia@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI Cancer
Moonshot Scholars Diversity Program R01
Meeting.
Date: March 1–2, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248 Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W248,
Rockville, Maryland 20850, 240–276–5007,
tandlea@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Research Specialist Award (R50).
Date: March 2–3, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Rockville,
Maryland 20850, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–7:
SBIR Contract Review.
E:\FR\FM\19DEN1.SGM
19DEN1
tkelley on DSK125TN23PROD with NOTICE
Federal Register / Vol. 87, No. 242 / Monday, December 19, 2022 / Notices
Date: March 2, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W608, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Patient
Derived Xenograft (PDX) Development and
Trial Centers (PDTCs) Network (U54 and
U24).
Date: March 2–3, 2023.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W238, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W238, Rockville, Maryland 20850,
240–276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–1:
SBIR Contract Review: Development of
Senotherapeutic Agents for Cancer
Treatment.
Date: March 8, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W246, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Rockville, Maryland 20850,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–2:
SBIR Contract Review.
Date: March 9, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W106, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, Maryland
20850, 240–276–7975, chufanee@
mail.nih.gov.
VerDate Sep<11>2014
19:38 Dec 16, 2022
Jkt 259001
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Research Specialist (Clinical Scientist)
Award (R50).
Date: March 10, 2023.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Rockville,
Maryland 20850, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4: NCI
Clinical and Translational Cancer Research.
Date: March 15, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W618, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: E. Tian, Ph.D., Scientific
Review Officer, Research Program Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room7W618, Rockville,
Maryland 20850, 240–276–6611, tiane@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–9: NCI
Clinical and Translational Cancer Research.
Date: March 22, 2023,
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W634, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Michael E. Lindquist,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W634, Rockville, Maryland 20850,
mike.lindquist@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–3: NCI
Clinical and Translational Cancer Research.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Mukesh Kumar, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W126,
Rockville, Maryland 20850, 240–276–6611,
mukesh.kumar3@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–1: NCI
Clinical and Translational Cancer Research.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
77625
Date: March 29, 2023.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Caterina Bianco, M.D.,
Ph.D., Chief, Scientific Review Officer,
Resources and Training Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Rockville, Maryland
20850, 240–276–6459, biancoc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–27417 Filed 12–16–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
SBIR Contract Review.
Date: January 24, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 87, Number 242 (Monday, December 19, 2022)]
[Notices]
[Pages 77624-77625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27417]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and contract proposals and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Survivorship Needs of Individuals with Advanced Cancer.
Date: January 12, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH 9609, Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 8A: Contract Review Meeting.
Date: February 1, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Program and Review Extramural Staff Training Office, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Integrating Biospecimen Science Approaches into Clinical
Assay Development.
Date: February 1, 2023.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP 8B: SBIR Review Meeting.
Date: February 2, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Program and Review Extramural Staff Training Office, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W534, Rockville, Maryland 20850, 240-276-6444,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Development of Informatics Technologies for Cancer Research
and Management.
Date: February 2, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Initial Review
Group; Institutional Training and Education Study Section (F).
Date: February 22-23, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Outstanding Investigator Award (R35).
Date: February 23-24, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W104, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: David G. Ransom, Ph.D., Chief, Scientific Review
Officer, Special Review Branch Division of Extramural Activities,
National Cancer Institute, NIH 9609, Medical Center Drive, Room
7W104, Rockville, Maryland 20850, 240-276-6351,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-3: SBIR Contract Review Meeting.
Date: February 24, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Cancer Moonshot Scholars Diversity Program R01 Meeting.
Date: March 1-2, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W248 Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Anita T. Tandle, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Rockville, Maryland 20850, 240-276-5007,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Specialist Award (R50).
Date: March 2-3, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850, 240-276-6372,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-7: SBIR Contract Review.
[[Page 77625]]
Date: March 2, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Patient Derived Xenograft (PDX) Development and Trial Centers
(PDTCs) Network (U54 and U24).
Date: March 2-3, 2023.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-1: SBIR Contract Review: Development of Senotherapeutic
Agents for Cancer Treatment.
Date: March 8, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-2: SBIR Contract Review.
Date: March 9, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Specialist (Clinical Scientist) Award (R50).
Date: March 10, 2023.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, Maryland 20850, 240-276-6372,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: March 15, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: E. Tian, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive,
Room7W618, Rockville, Maryland 20850, 240-276-6611,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
Date: March 22, 2023,
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W634, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Michael E. Lindquist, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Rockville, Maryland 20850,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational Cancer Research.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W126, Rockville, Maryland 20850, 240-276-6611,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-1: NCI Clinical and Translational Cancer Research.
Date: March 29, 2023.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Caterina Bianco, M.D., Ph.D., Chief, Scientific
Review Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850, 240-276-6459,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-27417 Filed 12-16-22; 8:45 am]
BILLING CODE 4140-01-P
